Seth Rudnick's Net Worth

$58.3 Million

Estimate Recalculated Jul 9, 2024 04:03PM EST

Who is Seth Rudnick?

Seth Rudnick has an estimated net worth of $58.3 Million. This is based on reported shares across multiple companies, which include GENAISSANCE PHARMACEUTICALS INC, IMMUNICON CORP, G1 Therapeutics, Inc., AMICUS THERAPEUTICS INC, Aralez Pharmaceuticals Inc., COMBINATORX, INC, POZEN INC /NC, ACTIVE NETWORK INC, SQUARE 1 FINANCIAL INC, Liquidia Technologies Inc, and Northstar Neuroscience, Inc..

SEC CIK

Seth Rudnick's CIK is 0001184420

Past Insider Trading and Trends

2018 was Seth Rudnick's most active year for acquiring shares with 7 total transactions. Seth Rudnick's most active month to acquire stocks was the month of May. 2018 was Seth Rudnick's most active year for disposing of shares, totalling 14 transactions. Seth Rudnick's most active month to dispose stocks was the month of September. 2016 saw Seth Rudnick paying a total of $143,121.00 for 130,001 shares, this is the most they've acquired in one year. In 2011 Seth Rudnick cashed out on 8,328,619 shares for a total of $20,575,515.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AMICUS THERAPEUTICS INC (FOLD) Snapshot price: $12.96

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.05M
—
—
2.05M
Jun 5
Form 3
—
0
—
—
0
No matching records found

ACTIVE NETWORK INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.68%
-194.49K
$16.00
-$3,111,814.40
5.09M
Mar 2 - Mar 5
Form 4
-2.55%
-138.19K
$16.00
-$2,211,224.42
5.28M
Feb 29 - Mar 1
Form 4
-2.53%
-140.70K
$15.92
-$2,239,632.15
5.42M
Feb 27 - Feb 28
Form 4
∞
5.59M
$15.00
-$20,575,515.00
5.59M
May 31
Form 3
—
0
—
—
0
No matching records found

GENAISSANCE PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-260.48K
—
—
0
Oct 6
Form 4
+35.30%
7.14K
—
—
27.38K
Jun 30
Form 4
+90.26%
9.6K
—
—
20.24K
Mar 31
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Oct 1
No matching records found

IMMUNICON CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Jan 28
Form 4
∞
17.27K
—
—
17.27K
Apr 21
Form 3
—
0
—
—
0
No matching records found

G1 Therapeutics, Inc. (GTHX) Snapshot price: $4.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$11.36
-$219,759.79
4.39K
Scheduled
Jun 29
Form 4
∞
4.39K
—
—
4.39K
Jun 17
Form 4
-14.93%
-924.00
$20.10
-$18,572.31
5.27K
Scheduled
Dec 24
Form 4
-83.83%
-32.09K
$20.27
-$650,458.23
6.19K
Scheduled
Dec 22 - Dec 23
Form 4
-33.72%
-19.48K
$20.22
-$393,898.94
38.28K
Scheduled
Dec 8 - Dec 10
Form 4
-0.89%
-520.00
$20.09
-$10,449.24
57.76K
Scheduled
Dec 1
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
$19.85
-$389,246.43
0
Scheduled
Dec 4
Form 4
—
0
$20.96
-$411,447.00
0
Scheduled
Nov 5
Form 4
—
0
$25.06
-$493,310.48
0
Scheduled
Oct 4
Form 4
—
0
$30.17
-$595,583.35
0
Scheduled
Sep 4
Form 4
—
0
$25.54
-$503,001.00
0
Scheduled
Aug 6
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jul 11
Form 4
+4.97%
2.76K
—
—
58.28K
May 22
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found